Tuesday, February 26, 2013

ZGNX

Zogenix (ZGNX) You'll want to mark March 1st on your calendar.That is zogenix pdufa date.That's the day the U.S. Food and Drug Administration is going to be passing down a decision in the company's Zohydro ER drug.The drug is just another version of hydrocone but in a extended release format.Which is good for stopping the abuse of pain killers.But the bad news is, the advisory panel that makes a recommendation to the FDA regarding new drug requests has recommended - by a margin of 11 to 2 - that the agency NOT approve Zohydro ER.This is why I have taken a short position in ZGNX.I will probably cover half  of my shares before mar 1 just to be on the safe side.And hold my free shares through the decision on mar 1.

No comments:

Post a Comment